These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. CD4 regulatory T cells in human cancer pathogenesis. Knutson KL; Disis ML; Salazar LG Cancer Immunol Immunother; 2007 Mar; 56(3):271-85. PubMed ID: 16819631 [TBL] [Abstract][Full Text] [Related]
3. Targeting regulatory T cells for anticancer therapy. D'Arena G; Deaglio S; Laurenti L; De Martino L; De Feo V; Fusco BM; Carella AM; Cascavilla N; Musto P Mini Rev Med Chem; 2011 Jun; 11(6):480-5. PubMed ID: 21561409 [TBL] [Abstract][Full Text] [Related]
4. [Anti-CCR4 mAb and regulatory T cells]. Kurose K; Ohue Y; Oka M Gan To Kagaku Ryoho; 2013 Sep; 40(9):1150-5. PubMed ID: 24047773 [TBL] [Abstract][Full Text] [Related]
5. Regulatory T cells: from bench to bedside. Jiang S Int Immunopharmacol; 2009 May; 9(5):515-7. PubMed ID: 19272465 [TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells: a review. Dasgupta A; Saxena R Natl Med J India; 2012; 25(6):341-51. PubMed ID: 23998865 [TBL] [Abstract][Full Text] [Related]
9. The Impact of Tregs on the Anticancer Immunity and the Efficacy of Immune Checkpoint Inhibitor Therapies. González-Navajas JM; Fan DD; Yang S; Yang FM; Lozano-Ruiz B; Shen L; Lee J Front Immunol; 2021; 12():625783. PubMed ID: 33717139 [TBL] [Abstract][Full Text] [Related]
10. Emerging roles of regulatory T cells in tumour progression and metastasis. Halvorsen EC; Mahmoud SM; Bennewith KL Cancer Metastasis Rev; 2014 Dec; 33(4):1025-41. PubMed ID: 25359584 [TBL] [Abstract][Full Text] [Related]
11. [Regulatory T cells: A target in anticancer immunotherapy]. Enokida T; Nishikawa H Nihon Rinsho; 2017 Feb; 75(2):181-187. PubMed ID: 30562850 [TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells in cancer. Mougiakakos D; Choudhury A; Lladser A; Kiessling R; Johansson CC Adv Cancer Res; 2010; 107():57-117. PubMed ID: 20399961 [TBL] [Abstract][Full Text] [Related]
13. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy. Wang H; Franco F; Ho PC Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935 [TBL] [Abstract][Full Text] [Related]
14. Regulatory T-cells are possible effect prediction markers of immunotherapy for cancer patients. Wada J; Yamasaki A; Nagai S; Yanai K; Fuchino K; Kameda C; Tanaka H; Koga K; Nakashima H; Nakamura M; Tanaka M; Katano M; Morisaki T Anticancer Res; 2008; 28(4C):2401-8. PubMed ID: 18751426 [TBL] [Abstract][Full Text] [Related]
15. The function and potential drug targets of tumour-associated Tregs for cancer immunotherapy. Yan S; Zhang Y; Sun B Sci China Life Sci; 2019 Feb; 62(2):179-186. PubMed ID: 30610537 [TBL] [Abstract][Full Text] [Related]